HEMATOLOGY

Featured Content

Anticoagulation Management in Patients with Cancer 7/18/2008

ABSTRACT: Cancer, chemotherapy, and surgery are conditions that increase the risk of the development of venous thromboembolism (VTE), a common and potentially life-threatening condition.

TAGS: CANCER | ONCOLOGY | ANTICOAGULATION | CLOTS | CHEMOTHERAPY | THROMBOEMBOLISM

Related CE

Advanced Topics in Medicare Part D: Assisting Patients Eligible for Low-Income Subsidies

Newer Insights into the Prevention of the Common Cold

The Role of Vaccination in the Prevention of Influenza

Pharmacotherapeutic Options for Chronic Insomnia

Advances in the Treatment of Chronic Stable Angina

Related Content

Advanced Topics in Medicare Part D: Assisting Patients Eligible for Low-Income Subsidies

Newer Insights into the Prevention of the Common Cold

The Role of Vaccination in the Prevention of Influenza

Pharmacotherapeutic Options for Chronic Insomnia

Advances in the Treatment of Chronic Stable Angina

ANTICOAGULATION Warfarin and Adverse Drug Events 2/20/2008 Warfarin, the oral anticoagulant most frequently used to control and prevent thromboembolic disorders, is increasingly common among seniors. TAGS: GERIATRICS \| ADVERSE EVENTS \| CARDIOVASCULAR \| INTERACTION \| ANTICOAGULATION \| WARFARIN Therapeutic Approaches to Coagulopathy in Cancer Patients 7/13/2007 ABSTRACT: In the United States, it is estimated that the frequency of venous thromboembolism (VTE) among cancer patients is approximately 1 in 200. TAGS: ONCOLOGY/HEMATOLOGY \| CANCER \| THROMBOSIS \| ONCOLOGY \| ANTICOAGULATION \| HEPARIN \| DALTEPARIN Topical of Imiquimod 5% Cream in Organ Transplant Recipients 4/17/2007 Skin cancer occurrence in organ transplant recipients (OTRs) is a rising phenomenon. TAGS: DERMATOLOGY \| ONCOLOGY/HEMATOLOGY \| THROMBOSIS \| ONCOLOGY \| ANTICOAGULATION \| IMIQUIMOD \| PROPHYLAXIS \| RISK FACTOR A New Era of Anticoagulation 3/21/2007 Thromboembolism is one of the leading causes of morbidity and mortality in the United States. TAGS: ONCOLOGY/HEMATOLOGY \| THROMBOSIS \| ONCOLOGY \| ANTICOAGULATION \| FONDAPARINUX \| BIVALIRUDIN Loading... Advertisement Loading...
Loading...

Advertisers Media Kit Contact Us Privacy Policy Editorial Staff Classifieds About USP

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2009 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.